CELLULAR GOODS PLC — Board/Management Information 2022

Aug 16, 2022

National Storage Mechanism | Additional information

RNS Number : 0864W

Cellular Goods PLC

16 August 2022

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Press release

16 August 2022

Cellular Goods PLC

('Cellular Goods' or 'the Company')

Appointment of new Chief Financial Officer

Cellular Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce the appointment of Bruna Nikolla as Chief Financial Officer.

Ms Nikolla who will also serve as Company Secretary, will become a Director and is expected to join Cellular Goods with effect from 22 August 2022. Ms Nikolla will take over from Simon Walters who will continue with his role until 1 September 2022 to ensure an orderly handover.

Ms Nikolla is a member of the Chartered Institute of Management Accountants and brings more than 15 years of financial, strategic and commercial experience across multiple sectors including eCommerce, luxury retail, international technology, software and telecommunications.

She has significant leadership experience within the premium consumer goods sector and previously served as Finance Director of Trinny London, a premium beauty and skincare brand founded by UK television presenter and makeover guru Trinny Woodall. During her tenure at Trinny London, Bruna led the pricing and commercial strategy in a high-growth period. Between 2018 and 2020 she served as Finance Director at luxury eyewear brand Tom Davies Ltd. where she maintained overall responsibility for controlling all UK and head office finance as well as supporting the wider operations of the business.

Anna Chokina, Chief Executive of Cellular Goods, commented: "I would like to welcome Bruna, who brings a wealth of experience in the eCommerce and luxury goods sectors that will strengthen our commercial, financial and strategic capabilities. I look forward to working closely with Bruna to drive the Company's growth and deliver long-term value for our shareholders.

"On behalf of the Board, I would also like to thank Simon for his support and valuable contribution over the course of Cellular's listing journey and its move to commercial operations. We wish him well in his future endeavours."

There is no further information to disclose in relation to Ms Nikolla's appointment in accordance with LR9.6.13.

For further information please contact:

Cellular Goods
Anna Chokina Chief Executive Investor Relations	via Tancredi +44 207 887 7633 ir@cellular-goods.com
Tennyson Securities
Corporate Broker Peter Krens	+44 207 186 9030
Novum Securities
Corporate Broker Colin Rowbury Jon Belliss	+44 207 399 9427
Tancredi Intelligent Communication
Media Relations Helen Humphrey Gabriela Amaya Garcia Charlie Hobbs cellulargoods@tancredigroup.com	+44 744 922 6720 +44 791 503 5294 +44 789 755 7112

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAPAMFTMTIBBIT